Inventor · disambiguated record
Yumiko Wada
Also filed as: WADA YUMIKO
25 granted patents·12 pending applications·539 citations·filing 1995–2020
97Inventor score
Files withSYNTA PHARMACEUTICALS CORP22SHIONOGI BIORES CORP3LU RONGZHEN2MADRIGAL PHARMACEUTICALS INC2ONO MITSUNORI2
Top patents by PatentIndex Score
37 records- 0196US7615552B2Fused heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Nov 10, 2009·87 cites·46 claims
- 0294US6858606B2Pyrimidine compoundsSYNTA PHARMACEUTICAL CORP·Filed 2002·Granted Feb 22, 2005·55 cites·30 claims
- 0394US6660733B22,4,6-trisubstituted-pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·69 cites·25 claims
- 0491US6958332B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 25, 2005·39 cites·32 claims
- 0590US7470685B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·11 cites·33 claims
- 0690US6680315B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2001·Granted Jan 20, 2004·34 cites·46 claims
- 0790US6384032B1Inhibitors of IL-12 productionSHIONOGI BIORES CORP·Filed 2000·Granted May 7, 2002·63 cites·36 claims
- 0889US7470681B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 30, 2008·12 cites·25 claims
- 0989US7122665B2Heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted Oct 17, 2006·29 cites·28 claims
- 1089US7045517B2Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2003·Granted May 16, 2006·37 cites·53 claims
- 1188US7465725B2Pyrimidine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 16, 2008·8 cites·37 claims
- 1286US7872005B22-substituted heteroaryl compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Jan 18, 2011·9 cites·34 claims
- 1385US7338951B2Pyridine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Mar 4, 2008·18 cites·44 claims
- 1481US8815945B2Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancersNAGAI MASAZUMI·Filed 2011·Granted Aug 26, 2014·4 cites·16 claims
- 1580US9910031B2Compositions and methods for modulating c-Rel-dependent cytokine productionSYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Mar 6, 2018·3 cites·18 claims
- 1678US8318730B2Fused hetrocyclic compoundsONO MITSUNORI·Filed 2009·Granted Nov 27, 2012·3 cites·2 claims
- 1777US7687498B2Pyridine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Mar 30, 2010·2 cites·21 claims
- 1877US7410990B2Heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Aug 12, 2008·2 cites·21 claims
- 1976US7851466B2Pyrimidine compounds and uses thereofSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Dec 14, 2010·6 cites·24 claims
- 2074US6433199B1Quinone derivativesSHIONOGI BIORES CORP·Filed 1999·Granted Aug 13, 2002·20 cites·8 claims
- 2173US8173651B2Pyridine compoundsONO MITSUNORI·Filed 2010·Granted May 8, 2012·2 cites·11 claims
- 2269US6462078B1Epoxyvibsanin BSHIONOGI BIORES CORP·Filed 2002·Granted Oct 8, 2002·4 cites·5 claims
- 2369US2021140945A1Methods of treating neurological diseases and disordersMADRIGAL PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2465US5969133ABioreductive cytotoxic agentsSHIONGI BIORESEARCH CORP·Filed 1998·Granted Oct 19, 1999·14 cites·21 claims
- 2562US2008227114A1Compositions and methods for modulating c-rel-dependent cytokine productionSYNTA PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 2661US2018217130A1Compositions and methods for treating systemic lupus erythematosusMADRIGAL PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2756US2005282232A1Compositions and methods for modulating c-Rel-dependent cytokine productionLU RONGZHEN·Filed 2004·Application pending·0 cites
- 2855US2012208203A1Compositions and methods for modulating c-rel-dependent cytokine productionLU RONGZHEN·Filed 2012·Application pending·0 cites
- 2953US2006069090A1Triazine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 3052US2008058297A1Heterocyclic Compounds For Preventing And Treating Disorders Associated With Excessive Bone LossSYNTA PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 3150US2011098267A1Topical formulations for the treatment of psoriasisSYNTA PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 3249US2014329892A1Administration of a bis(thiohydrazide amide) compound for treating cancersSYNTA PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 3348US7935698B2Heteroaryl-hydrazone compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted May 3, 2011·0 cites·45 claims
- 3447US5589510AMethod for inhibiting retroviral infection by administering a naphthalenesulfonic acid compoundFUJI IMMUNOPHARMACEUTICALS COR·Filed 1995·Granted Dec 31, 1996·8 cites·14 claims
- 3547US2005203119A1Dihydropyridine compounds for treating or preventing metabolic disordersFiled 2004·Application pending·0 cites
- 3643US2010120722A1Heterocyclic compounds for preventing and treating disorders associated with excessive bone lossSYNTA PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
- 3734US2011288081A1Pyrimidine compounds and uses thereofWADA YUMIKO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yumiko Wada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →